IGC PHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $893.0K | $34.5M | $25.6M |
| FY2020 | $2.4M | $29.0M | $7.3M |
| FY2021 | $3.1M | $35.9M | $14.5M |
| FY2022 | $2.9M | $26.8M | $10.5M |
| FY2023 | $2.3M | $17.2M | $3.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $893.0K | $34.5M | $25.6M |
| FY2020 | $2.4M | $29.0M | $7.3M |
| FY2021 | $3.1M | $35.9M | $14.5M |
| FY2022 | $2.9M | $26.8M | $10.5M |
| FY2023 | $2.3M | $17.2M | $3.2M |